Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Niels Gyldenkerne"'
Autor:
Ruta Zukauskaite, Christopher N. Rumley, Christian R. Hansen, Michael G. Jameson, Yuvnik Trada, Jørgen Johansen, Niels Gyldenkerne, Jesper G. Eriksen, Farhannah Aly, Rasmus L. Christensen, Mark Lee, Carsten Brink, Lois Holloway
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 36, Iss , Pp 121-126 (2022)
Background: During the last decade, radiotherapy using MR Linac has gone from research to clinical implementation for different cancer locations. For head and neck cancer (HNC), target delineation based only on MR images is not yet standard, and the
Externí odkaz:
https://doaj.org/article/c35a7e8bd1694803bc77a7d4282c070d
Autor:
Christian Rønn Hansen, Anders Bertelsen, Irene Hazell, Ruta Zukauskaite, Niels Gyldenkerne, Jørgen Johansen, Jesper G. Eriksen, Carsten Brink
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 1, Iss C, Pp 2-8 (2016)
Background: Treatment plans for head and neck (H&N) cancer are highly complex due to multiple dose prescription levels and numerous organs at risk (OARs) close to the target. The plan quality is inter-planner dependent since it is dependent on the sk
Externí odkaz:
https://doaj.org/article/5d86df2a87d444b1aed00ceee694a2a8
Autor:
Sebastian Søby, Anita Gothelf, Niels Gyldenkerne, Jens Bentzen, Kinga Nowicka-Matus, Trine Tramm, Jesper Grau Eriksen
Publikováno v:
Søby, S, Gothelf, A, Gyldenkerne, N, Bentzen, J, Nowicka-Matus, K, Tramm, T & Eriksen, J G 2022, ' Efficacy of nivolumab as second line treatment for recurrent or metastatic head and neck squamous cell carcinoma : a national DAHANCA cohort study ', Acta Oncologica, vol. 61, no. 8, pp. 972-978 . https://doi.org/10.1080/0284186X.2022.2103387
Søby, S, Gothelf, A, Gyldenkerne, N, Bentzen, J, Nowicka-Matus, K, Tramm, T & Eriksen, J G 2022, ' Efficacy of nivolumab as second line treatment for recurrent or metastatic Head and Neck Squamous Cell Carcinoma : A national DAHANCA cohort study ', Acta Oncologica, vol. 61, no. 8, pp. 972-978 . https://doi.org/10.1080/0284186X.2022.2103387
Søby, S, Gothelf, A, Gyldenkerne, N, Bentzen, J, Nowicka-Matus, K, Tramm, T & Eriksen, J G 2022, ' Efficacy of nivolumab as second line treatment for recurrent or metastatic Head and Neck Squamous Cell Carcinoma : A national DAHANCA cohort study ', Acta Oncologica, vol. 61, no. 8, pp. 972-978 . https://doi.org/10.1080/0284186X.2022.2103387
Introduction: The aim of this study was to investigate phase IV efficacy, of the PD-1 inhibitor nivolumab among an unselected and unbiased national cohort of recurrent/metastatic Head and Neck Squamous Cell Carcinoma (rmHNSCC) patients. Material and
Autor:
Barbara Burtness, Kevin J Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Basté, Prakash Neupane, Åse Bratland, Thorsten Fuereder, Brett G M Hughes, Ricard Mesía, Nuttapong Ngamphaiboon, Tamara Rordorf, Wan Zamaniah Wan Ishak, Ruey-Long Hong, René González Mendoza, Ananya Roy, Yayan Zhang, Burak Gumuscu, Jonathan D Cheng, Fan Jin, Danny Rischin, Guillermo Lerzo, Marcelo Tatangelo, Mirta Varela, Juan Jose Zarba, Michael Boyer, Hui Gan, Bo Gao, Brett Hughes, Girish Mallesara, Anne Taylor, Martin Burian, Carlos Henrique Barrios, Dalvaro Oliveira de Castro Junior, Gilberto Castro, Fabio Andre Franke, Gustavo Girotto, Iane Pinto Figueiredo Lima, Ulisses Ribaldo Nicolau, Gustavo Dix Junqueira Pinto, Lucas Santos, Ana-Paula Victorino, Neil Chua, Felix Couture, Richard Gregg, Aaron Hansen, John Hilton, Joy McCarthy, Denis Soulieres, Rodrigo Ascui, Pablo Gonzalez, Luis Villanueva, Marco Torregroza, Angela Zambrano, Petra Holeckova, Zdenek Kral, Bohuslav Melichar, Jana Prausova, Milan Vosmik, Maria Andersen, Niels Gyldenkerne, Hannes Jurgens, Kadri Putnik, Petri Reinikainen, Viktor Gruenwald, Simon Laban, Gerasimos Aravantinos, Ioannis Boukovinas, Vassilis Georgoulias, Dora Kwong, Yousuf Al-Farhat, Tibor Csoszi, Jozsef Erfan, Geza Horvai, Laszlo Landherr, Eva Remenar, Agnes Ruzsa, Judit Szota, Salem Billan, Iris Gluck, Orit Gutfeld, Aron Popovtzer, Marco Benasso, Simona Bui, Vittorio Ferrari, Lisa Licitra, Franco Nole, Takashi Fujii, Yasushi Fujimoto, Nobuhiro Hanai, Hiroki Hara, Koji Matsumoto, Kenji Mitsugi, Nobuya Monden, Masahiro Nakayama, Kenji Okami, Nobuhiko Oridate, Kiyoto Shiga, Yasushi Shimizu, Masashi Sugasawa, Masanobu Takahashi, Shunji Takahashi, Kaoru Tanaka, Tsutomu Ueda, Hironori Yamaguchi, Tomoko Yamazaki, Ryuji Yasumatsu, Tomoya Yokota, Tomokazu Yoshizaki, Iveta Kudaba, Zinaida Stara, Soon Keat Cheah, Jose Aguilar Ponce, Rene Gonzalez Mendoza, Carlos Hernandez Hernandez, Francisco Medina Soto, Jan Buter, Ann Hoeben, S. Oosting, Karijn Suijkerbuijk, Aase Bratland, Marianne Brydoey, Renzo Alvarez, Luis Mas, Priscilla Caguioa, John Querol, Eugenio Emmanuel Regala, Maria Belen Tamayo, Ellie May Villegas, Andrzej Kawecki, Andrey Karpenko, Arkadiy Klochikhin, Alexey Smolin, Oleg Zarubenkov, Boon Cher Goh, Graham Cohen, Johanna du Toit, Christa Jordaan, Gregory Landers, Paul Ruff, Waldemar Szpak, Neonyana Tabane, Irene Brana, Lara Iglesias Docampo, Javier Lavernia, Ricard Mesia, Edvard Abel, Valentina Muratidu, Niels Nielsen, Valerie Cristina, Sacha Rothschild, Hung-Ming Wang, Muh-Hwa Yang, Su-Peng Yeh, Chia-Jui Yen, Nopadol Soparattanapaisarn, Virote Sriuranpong, Sercan Aksoy, Irfan Cicin, Meltem Ekenel, Hakan Harputluoglu, Ozgur Ozyilkan, Kevin Harrington, Sanjiv Agarwala, Haythem Ali, Robert Alter, Daniel Anderson, Justine Bruce, Nicholas Campbell, Miguel Conde, John Deeken, William Edenfield, Lawrence Feldman, Elizabeth Gaughan, Basem Goueli, Balazs Halmos, Upendra Hegde, Brian Hunis, Robert Jotte, Anand Karnad, Saad Khan, Noel Laudi, Douglas Laux, Danko Martincic, Steven McCune, Dean McGaughey, Krzysztof Misiukiewicz, Deborah Mulford, Eric Nadler, Johannes Nunnink, James Ohr, Meaghan O'Malley, Brian Patson, Doru Paul, Elizabeta Popa, Steven Powell, Rebecca Redman, Vincent Rella, Chaio Rocha Lima, Abirami Sivapiragasam, Yungpo Su, Ammar Sukari, Stuart Wong, Emrullah Yilmaz, Jeffrey Yorio
Publikováno v:
The Lancet, 394(10212), 1915-1928. ELSEVIER SCIENCE INC
BACKGROUND: Pembrolizumab is active in head and neck squamous cell carcinoma (HNSCC), with programmed cell death ligand 1 (PD-L1) expression associated with improved response.METHODS: KEYNOTE-048 was a randomised, phase 3 study of participants with u
Autor:
Oke Gerke, Christian Godballe, Anne Lerberg Nielsen, Poul Flemming Høilund-Carlsen, Jens Ahm Sørensen, Manan Pareek, Kristine Bjørndal, Max Rohde, Anabel Diaz, Niels Gyldenkerne, Helle Døssing, Anders Thomassen, Jon Thor Asmussen, Jørgen Johansen
Publikováno v:
Rohde, M, Nielsen, A L, Johansen, J, Sørensen, J A, Diaz, A, Pareek, M, Asmussen, J T, Gerke, O, Thomassen, A, Gyldenkerne, N, Døssing, H, Bjørndal, K, Høilund-Carlsen, P F & Godballe, C 2019, ' Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma ', Oral Oncology, vol. 94, pp. 1-7 . https://doi.org/10.1016/j.oraloncology.2019.04.025
Purpose: To compare multidisciplinary team conference (MDTC) decisions regarding treatment intent based on either chest X-ray + MRI of the head and neck (CXR/MRI) or 18 F-FDG-PET/CT (PET/CT) in patients with recurrent head and neck squamous cell carc
Autor:
G. Hanahan, Z. G. Zimling, Pernille Lassen, Jeppe Friborg, Jens Overgaard, C. K. Lønkvist, Jesper Grau Eriksen, A. L. Linnet Nielsen, Niels Gyldenkerne, K. Nowicka-Matus, Anita Gothelf
Publikováno v:
Radiotherapy and Oncology. 161:S1157-S1158
Autor:
Irene Hazell, Vibeke N. Hansen, Christian Rønn Hansen, Carsten Brink, J. Johansen, Ruta Zukauskaite, Anders Bertelsen, Uffe Bernchou, Niels Gyldenkerne, Ebbe Laugaard Lorenzen
Publikováno v:
Radiotherapy and Oncology. 161:S658-S659
Autor:
Jesper Grau Eriksen, Christian Rønn Hansen, Rasmus Lübeck Christiansen, Jon Thor Asmussen, Carsten Brink, Niels Gyldenkerne, Anders Bertelsen, Jørgen Johansen, Ebbe Laugaard Lorenzen
Publikováno v:
Hansen, C R, Lübeck Christiansen, R, Lorenzen, E L, Bertelsen, A S, Asmussen, J T, Gyldenkerne, N, Eriksen, J G, Johansen, J & Brink, C 2017, ' Contouring and dose calculation in head and neck cancer radiotherapy after reduction of metal artifacts in CT images ', Acta Oncologica, vol. 56, no. 6, pp. 874-878 . https://doi.org/10.1080/0284186X.2017.1287427
Background: Delineation accuracy of the gross tumor volume (GTV) in radiotherapy planning for head and neck (H&N) cancer is affected by computed tomography (CT) artifacts from metal implants which obscure identification of tumor as well as organs at
Autor:
Niels Gyldenkerne, Jesper Grau Eriksen, Christian Rønn Hansen, Ruta Zukauskaite, Carsten Brink, Irene Hazell, Anders Bertelsen, Jørgen Johansen
Publikováno v:
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology, Vol 1, Iss C, Pp 2-8 (2016)
Hansen, C R, Bertelsen, A, Hazell, I, Zukauskaite, R, Gyldenkerne, N, Johansen, J, Eriksen, J G & Brink, C 2016, ' Automatic treatment planning improves the clinical quality of Head and Neck cancer treatment plans ', Clinical and Translational Radiation Oncology, vol. 1, pp. 2–8 . https://doi.org/10.1016/j.ctro.2016.08.001
Clinical and Translational Radiation Oncology, Vol 1, Iss C, Pp 2-8 (2016)
Hansen, C R, Bertelsen, A, Hazell, I, Zukauskaite, R, Gyldenkerne, N, Johansen, J, Eriksen, J G & Brink, C 2016, ' Automatic treatment planning improves the clinical quality of Head and Neck cancer treatment plans ', Clinical and Translational Radiation Oncology, vol. 1, pp. 2–8 . https://doi.org/10.1016/j.ctro.2016.08.001
Highlights • Autoplan can produce clinically better VMAT radiotherapy plans for H&N cancer. • Autoplan plans have similar target coverage with significant sparing of OAR. • With a template the TPS can automatically create better plans than manu
Autor:
C. Rumley, M. Heinke, J.G. Eriksen, Min Ha Lee, R.L. Christensen, Michael G Jameson, Lois Holloway, Jørgen Johansen, Niels Gyldenkerne, Y. Trada, Ruta Zukauskaite, Christian Rønn Hansen, Carsten Brink, Farhannah Aly
Publikováno v:
Radiotherapy and Oncology. 152:S434